Abstract B026: Targeting the novel tumor antigen MT1-MMP with Bicycle® Drug Conjugates (BDC®) for the potential treatment of NSCLC and other solid tumor indications
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Steve B. Ludbrook, Stephen Walsh, Gemma Mudd, Johanna Lahdenranta, Philip Huxley, Luca Mascheroni, Maximillian Harman, Jennifer Bré, Inma Rioja, Michael Skynner, Gavin Bennett
Institution: Cambridge Science Centre
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444740
Cites:
Cited by:
Related to: